Mural Oncology plc (NASDAQ: MURA) Stock Information | RedChip

Mural Oncology plc (NASDAQ: MURA)


$3.3400
-0.0300 ( -0.89% ) 28.1K

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Market Data


Open


$3.3400

Previous close


$3.3700

Volume


28.1K

Market cap


$57.32M

Day range


$3.3100 - $3.3700

52 week range


$2.8800 - $6.2499

SEC Filings


Form Type Description Pages Date
4/a Other 1 Apr 11, 2024
8-k 8K-related 14 Mar 26, 2024
10-k Annual reports 98 Mar 26, 2024
4 Insider transactions 1 Mar 04, 2024
4 Insider transactions 1 Mar 04, 2024
8-k 8K-related 40 Jan 08, 2024
4 Insider transactions 1 Dec 18, 2023
4 Insider transactions 1 Dec 18, 2023
4 Insider transactions 1 Dec 18, 2023
4 Insider transactions 1 Dec 18, 2023

Latest News